ProCon Medical OÜ

11071397

General info

Name

ProCon Medical OÜ

Registry code

11071397

VAT number

EE100929366

Type

OÜ - Limited Liability Company

Status

Registered

Foundation date

29.09.2004 (20)

Financial year

01.01-31.12

Capital

2 556.00 €

Activity

68201 - Rental and operating of own or leased real estate 86221 - Provision of specialised medical treatment 47911 - Retail sale via mail order houses or via Internet

Revenue

-

Profit

-

Profit margin

-

Gross salary

-

Equity

-

Employees

-

Annual report

Not submitted

Tax arrears

No tax arrears

Return on equity

-

Return on assets

-

Related parties

Owner Representative Beneficial owner Roles

Jüri Salumäe

28.12.1969 (54)

100% - 2 556.00 EUR Board member Direct ownership Founder

Related companies

Owner Representative Beneficial owner Roles

ModulEnergy OÜ

12763915

- - - Founder

Financial info

2019
27.10.2020
2020
30.06.2021
2021
30.06.2022
2022
30.06.2023
Total Revenue 1 020 € 2 571 € 35 216 € 59 308 €
Net profit (loss) for the period 1 348 € -427 € 182 € -20 669 €
Profit Margin 132% -17% 1% -35%
Current Assets 17 711 € 21 317 € 61 915 € 42 669 €
Fixed Assets 1 333 € 1 333 € 0 € -
Total Assets 19 044 € 22 650 € 61 915 € 42 669 €
Current Liabilities - 4 033 € 43 116 € 29 539 €
Non Current Liabilities - - - -
Total Liabilities - - - -
Share Capital - - - -
Equity 19 044 € 18 617 € 18 799 € 13 130 €
Employees 0 0 0 0

Paid taxes, taxable turnover and number of employees

Turnover
State taxes
Labor taxes and payments
Employees
2024 Q1 497.94 € - - 1
2023 Q4 310.37 € 71.81 € - -
2023 Q3 984.51 € 629.05 € 391.67 € -
2023 Q2 1 705.79 € 876.95 € 391.67 € -
2023 Q1 6 650.3 € 1 251.36 € - -
2022 Q4 18 891.55 € 2 875.62 € - -
2022 Q3 10 790.78 € 1 403.07 € - -
2022 Q2 17 807.82 € 2 865.51 € - -
2022 Q1 21 818.88 € 2 209.7 € - -
2021 Q4 20 696.09 € 1 001.55 € - -
2021 Q3 10 950.31 € - - -
2021 Q2 6 996.39 € 275.6 € - -
2021 Q1 4 117.82 € 1 230.45 € - -
2020 Q4 168.35 € 23.42 € - -
2020 Q3 1 520.61 € 117.27 € - -
2020 Q2 505 € - - -
2020 Q1 - - - -